Discover the full record of transactions filed by Carter Laura, Chief Scientific Officer. Officer active across 1 companies, notably Gossamer Bio, Inc.. Aggregated, 8 reports have been published. Total volume traded: €96k. The latest transaction was disclosed on 4 May 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Laura Carter is the Chief Scientific Officer at Gossamer Bio, Inc. She oversees research and development initiatives aimed at innovating in the biotechnology field. Carter is recognized for her scientific expertise and commitment to advancing medical treatments.